Compound ID | 1803
Amurin
Class: Amurin
| Spectrum of activity: | Gram-negative |
| Details of activity: | Active against Gram-negative bacteria. Phage-encoded lytic outer membrane targeting peptides |
| Description: | Phage-encoded lytic antimicrobial peptide. Developed as inhalation therapy. |
| Institute where first reported: | ContraFect |
| Year first mentioned: | 2019 |
| Highest developmental phase: | Preclinical |
| Development status: | Active (as of 2022) |
| External links: | |
| UniProt link: | https://www.uniprot.org/uniprotkb/A0AAS1/entry |
| Citations: |
|
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.